{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:28:29Z","timestamp":1784629709209,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J011347"],"award-info":[{"award-number":["2021J011347"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J05297"],"award-info":[{"award-number":["2021J05297"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871145"],"award-info":[{"award-number":["81871145"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Endometriosis (EMs) is a condition characterized by the growth of endometrial tissue outside the uterine cavity. Although this condition is benign, it has cancer-like features. N6-methyladenosine (m6A) is a common RNA modification involved in diverse biological processes, but its role in EMs remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A human endometrial stromal cell line (HESCs), primary eutopic endometrial stromal cells (Eu-ESCs), primary ectopic endometrial stromal cells (Ec-ESCs), and clinical samples were used in this study. A colorimetric assay was used to measure methylation levels in clinical and mouse EMs samples. Functional assays (CCK-8, EdU, Transwell, and wound healing) were used to evaluate phenotypic changes. m6A immunoprecipitation sequencing (MeRIP-seq) identified downstream targets. Mechanistic studies were conducted via qRT\u2012PCR, Western blot, RNA immunoprecipitation (RIP), dual-luciferase reporter, and RNA stability assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We detected aberrantly low levels of m6A within endometriotic lesions, which was attributed to increased expression of the m6A eraser fat mass and obesity-associated protein (FTO). Notably, estrogen and inflammatory factors, which are recognized as pathogenic agents in EMs amplify FTO expression while suppressing m6A levels. In vitro experiments demonstrated that overexpression of FTO in endometrial stromal cells leads to a reduction in m6A levels and concomitantly promotes their proliferation, migration, and invasion. Furthermore, both genetic deletion of <jats:italic>Fto<\/jats:italic> and chemical inhibition of FTO impeded the growth of ectopic endometrial lesions in vivo. By utilizing m6A-seq, we identified GEF-H1 (a Rho guanine nucleotide exchange factor) as a pivotal downstream target of FTO. Specifically, diminished m6A methylation at a certain site within the 3'UTR of GEF-H1 promotes its expression in a YTH N6-methyladenosine RNA-binding protein F1 (YTHDF1)-dependent manner, thereby activating the RhoA pathway. Subsequent experiments revealed that GEF-H1 mediates the effects of FTO in promoting migration and invasion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study revealed that FTO decreases the m6A level of <jats:italic>GEF-H1<\/jats:italic>, thereby increasing its stability, which in turn activates the GEF-H1-RhoA pathway to promote the migration and invasion of endometrial stromal cells, thereby inducing EMs. Our findings suggest potential therapeutic avenues for targeting FTO to alleviate EMs progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10020-025-01130-8","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T12:39:52Z","timestamp":1740487192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel mechanism of FTO modulating the progression of endometriosis through mediating the m6A methylation of GEF-H1 in a YTHDF1-dependent manner"],"prefix":"10.1186","volume":"31","author":[{"given":"Xin-Yu","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Kun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Bin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian-Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Fa","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Lu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1503\/cmaj.220637","volume":"195","author":"C Allaire","year":"2023","unstructured":"Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ Can Med Assoc J. 2023;195:E363\u201371.","journal-title":"CMAJ Can Med Assoc J"},{"key":"1130_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.fertnstert.2017.05.004","volume":"108","author":"CM Becker","year":"2017","unstructured":"Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017;108:125\u201336.","journal-title":"Fertil Steril"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","volume":"15","author":"C Chapron","year":"2019","unstructured":"Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15:666\u201382.","journal-title":"Nat Rev Endocrinol"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen B, Ye F, Yu L, Jia G, Huang X, Zhang X, Peng S, Chen K, Wang M, Gong S, et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012;134:17963\u201371.","journal-title":"J Am Chem Soc"},{"key":"1130_CR5","doi-asserted-by":"publisher","first-page":"1162607","DOI":"10.3389\/fimmu.2023.1162607","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L, Gao Y, Xu S, Yuan J, Wang M, Li T, Gong J. N6-methyladenosine reader YTHDF family in biological processes: structures, roles, and mechanisms. Front Immunol. 2023;14:1162607.","journal-title":"Front Immunol"},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","volume":"420","author":"S Etienne-Manneville","year":"2002","unstructured":"Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629\u201335.","journal-title":"Nature"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2015.10.034","volume":"163","author":"SJ Han","year":"2015","unstructured":"Han SJ, Jung SY, Wu S-P, Hawkins SM, Park MJ, Kyo S, Qin J, Lydon JP, Tsai SY, Tsai M-J, et al. Estrogen receptor \u03b2 modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163:960\u201374.","journal-title":"Cell"},{"key":"1130_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070750","volume":"379","author":"AW Horne","year":"2022","unstructured":"Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379: e070750.","journal-title":"BMJ"},{"key":"1130_CR9","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.1111\/jcmm.15689","volume":"24","author":"Z-X Huang","year":"2020","unstructured":"Huang Z-X, Mao X-M, Wu R-F, Huang S-M, Ding X-Y, Chen Q-H, Chen Q-X. RhoA\/ROCK pathway mediates the effect of oestrogen on regulating epithelial-mesenchymal transition and proliferation in endometriosis. J Cell Mol Med. 2020;24:10693\u2013704.","journal-title":"J Cell Mol Med"},{"key":"1130_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","volume":"14","author":"W Huang","year":"2021","unstructured":"Huang W, Chen T-Q, Fang K, Zeng Z-C, Ye H, Chen Y-Q. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. J Hematol Oncol. 2021;14:117.","journal-title":"J Hematol Oncol"},{"key":"1130_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang Y-G, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"1130_CR12","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.7150\/thno.45178","volume":"10","author":"D Jian","year":"2020","unstructured":"Jian D, Wang Y, Jian L, Tang H, Rao L, Chen K, Jia Z, Zhang W, Liu Y, Chen X, et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics. 2020;10:8939\u201356.","journal-title":"Theranostics"},{"key":"1130_CR13","doi-asserted-by":"publisher","first-page":"25916","DOI":"10.18632\/aging.202163","volume":"12","author":"L Jiang","year":"2020","unstructured":"Jiang L, Zhang M, Wu J, Wang S, Yang X, Yi M, Zhang X, Fang X. Exploring diagnostic m6A regulators in endometriosis. Aging. 2020;12:25916\u201338.","journal-title":"Aging"},{"key":"1130_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/humupd\/dmy004","volume":"24","author":"B Leeners","year":"2018","unstructured":"Leeners B, Damaso F, Ochsenbein-K\u00f6lble N, Farquhar C. The effect of pregnancy on endometriosis-facts or fiction? Hum Reprod Update. 2018;24:290\u20139.","journal-title":"Hum Reprod Update"},{"key":"1130_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"1130_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/biolre\/ioab152","volume":"105","author":"X Li","year":"2021","unstructured":"Li X, Xiong W, Long X, Dai X, Peng Y, Xu Y, Zhang Z, Zhang L, Liu Y. Inhibition of METTL3\/m6A\/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis\u2020. Biol Reprod. 2021;105:1221\u201333.","journal-title":"Biol Reprod"},{"key":"1130_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1564","volume":"14","author":"X Lin","year":"2024","unstructured":"Lin X, Dai Y, Gu W, Zhang Y, Zhuo F, Zhao F, Jin X, Li C, Huang D, Tong X, et al. The involvement of RNA N6-methyladenosine and histone methylation modification in decidualization and endometriosis-associated infertility. Clin Transl Med. 2024;14: e1564.","journal-title":"Clin Transl Med"},{"key":"1130_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nsmb.3162","volume":"23","author":"N Liu","year":"2016","unstructured":"Liu N, Pan T. N6-methyladenosine\u2013encoded epitranscriptomics. Nat Struct Mol Biol. 2016;23:98\u2013102.","journal-title":"Nat Struct Mol Biol"},{"key":"1130_CR19","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu J, Eckert MA, Harada BT, Liu S-M, Lu Z, Yu K, Tienda SM, Chryplewicz A, Zhu AC, Yang Y, et al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20:1074\u201383.","journal-title":"Nat Cell Biol"},{"key":"1130_CR20","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.3390\/ijms20153822","volume":"20","author":"RM Marquardt","year":"2019","unstructured":"Marquardt RM, Kim TH, Shin J-H, Jeong J-W. Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis? Int J Mol Sci. 2019;20:3822.","journal-title":"Int J Mol Sci"},{"key":"1130_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1210\/endrev\/bnad020","volume":"44","author":"RM Marquardt","year":"2023","unstructured":"Marquardt RM, Tran DN, Lessey BA, Rahman MS, Jeong J-W. Epigenetic dysregulation in endometriosis: implications for pathophysiology and therapeutics. Endocr Rev. 2023;44:1074\u201395.","journal-title":"Endocr Rev"},{"key":"1130_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.fertnstert.2018.06.025","volume":"110","author":"L Muzii","year":"2018","unstructured":"Muzii L, Di Tucci C, Di Feliciantonio M, Galati G, Di Donato V, Musella A, Palaia I, Panici PB. Antim\u00fcllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis. Fertil Steril. 2018;110:932-940.e1.","journal-title":"Fertil Steril"},{"key":"1130_CR23","volume":"2016","author":"V Nisenblat","year":"2016","unstructured":"Nisenblat V, Bossuyt PMM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, Mol BWJ, Johnson N, Hull ML. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016: 012179.","journal-title":"Cochrane Database Syst Rev"},{"key":"1130_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gpb.2012.12.002","volume":"11","author":"Y Niu","year":"2013","unstructured":"Niu Y, Zhao X, Wu Y-S, Li M-M, Wang X-J, Yang Y-G. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinform. 2013;11:8\u201317.","journal-title":"Genomics Proteomics Bioinform"},{"key":"1130_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, Wang Y, Li X, Xiong X-F, Wei B, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18:46.","journal-title":"Mol Cancer"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR. Reading m6A in the transcriptome: m6A-binding proteins. Trends Cell Biol. 2018;28:113\u201327.","journal-title":"Trends Cell Biol"},{"key":"1130_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/humrep\/deaa017","volume":"35","author":"B Peng","year":"2020","unstructured":"Peng B, Alotaibi FT, Sediqi S, Bedaiwy MA, Yong PJ. Role of interleukin-1\u03b2 in nerve growth factor expression, neurogenesis and deep dyspareunia in endometriosis. Hum Reprod Oxf Engl. 2020;35:901\u201312.","journal-title":"Hum Reprod Oxf Engl"},{"key":"1130_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/humupd\/dmw031","volume":"22","author":"N Pluchino","year":"2016","unstructured":"Pluchino N, Wenger J-M, Petignat P, Tal R, Bolmont M, Taylor HS, Bianchi-Demicheli F. Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment. Hum Reprod Update. 2016;22:762\u201374.","journal-title":"Hum Reprod Update"},{"key":"1130_CR29","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1242\/jcs.114.15.2713","volume":"114","author":"AJ Ridley","year":"2001","unstructured":"Ridley AJ. Rho GTPases and cell migration. J Cell Sci. 2001;114:2713\u201322.","journal-title":"J Cell Sci"},{"key":"1130_CR30","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1092053","volume":"302","author":"AJ Ridley","year":"2003","unstructured":"Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science. 2003;302:1704\u20139.","journal-title":"Science"},{"key":"1130_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/10408363.2023.2270736","volume":"61","author":"M Samare-Najaf","year":"2024","unstructured":"Samare-Najaf M, Razavinasab SA, Samareh A, Jamali N. Omics-based novel strategies in the diagnosis of endometriosis. Crit Rev Clin Lab Sci. 2024;61:205\u201325.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1130_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/jcmm.15997","volume":"25","author":"Y Shen","year":"2021","unstructured":"Shen Y, Li C, Zhou L, Huang J-A. G protein-coupled oestrogen receptor promotes cell growth of non-small cell lung cancer cells via YAP1\/QKI\/circNOTCH1\/m6A methylated NOTCH1 signalling. J Cell Mol Med. 2021;25:284\u201396.","journal-title":"J Cell Mol Med"},{"key":"1130_CR33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/humrep\/des073","volume":"27","author":"S Simoens","year":"2012","unstructured":"Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod Oxf Engl. 2012;27:1292\u20139.","journal-title":"Hum Reprod Oxf Engl"},{"key":"1130_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79-96.e11.","journal-title":"Cancer Cell"},{"key":"1130_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","volume":"397","author":"HS Taylor","year":"2021","unstructured":"Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet Lond Engl. 2021;397:839\u201352.","journal-title":"Lancet Lond Engl"},{"key":"1130_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/15476286.2017.1282025","volume":"14","author":"X Wang","year":"2017","unstructured":"Wang X, Huang J, Zou T, Yin P. Human m6A writers: two subunits, 2 roles. RNA Biol. 2017;14:300\u20134.","journal-title":"RNA Biol"},{"key":"1130_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110406","volume":"98","author":"H Wang","year":"2022","unstructured":"Wang H, Liang Z, Gou Y, Li Z, Cao Y, Jiao N, Tan J, Yu Y, Zhang Z. FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5\/PKM2 Axis. Cell Signal. 2022;98: 110406.","journal-title":"Cell Signal"},{"key":"1130_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12967-023-04209-0","volume":"21","author":"X Wang","year":"2023","unstructured":"Wang X, Wang J, Zhao X, Wu H, Li J, Cheng Y, Guo Q, Cao X, Liang T, Sun L, et al. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing. J Transl Med. 2023a;21:407.","journal-title":"J Transl Med"},{"key":"1130_CR39","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/ijms24021665","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Zhao X, Wang J, Wu H, Cheng Y, Guo Q, Liang T, Zhang G. Cross-talk between N6-methyladenosine and their related RNAs defined a signature and confirmed m6A regulators for diagnosis of endometriosis. Int J Mol Sci. 2023b;24:1665.","journal-title":"Int J Mol Sci"},{"key":"1130_CR40","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1258\/ebm.2010.009321","volume":"235","author":"M-H Wu","year":"2010","unstructured":"Wu M-H, Lu C-W, Chuang P-C, Tsai S-J. Prostaglandin E2: the master of endometriosis? Exp Biol Med Maywood NJ. 2010;235:668\u201377.","journal-title":"Exp Biol Med Maywood NJ"},{"key":"1130_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen Y-S, Yang Y-G. Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616\u201324.","journal-title":"Cell Res"},{"key":"1130_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41420-024-01893-9","volume":"10","author":"Z Yang","year":"2024","unstructured":"Yang Z, Yu W, Xu A, Liu B, Jin L, Tao H, Wang D. mTORC1 accelerates osteosarcoma progression via m6A-dependent stabilization of USP7 mRNA. Cell Death Discov. 2024;10:127.","journal-title":"Cell Death Discov"},{"key":"1130_CR43","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","volume":"181","author":"S Zaccara","year":"2020","unstructured":"Zaccara S, Jaffrey SR. A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA. Cell. 2020;181:1582-1595.e18.","journal-title":"Cell"},{"key":"1130_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1130_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2011.12.033","volume":"319","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhou D, Lai Y, Liu Y, Tao X, Wang Q, Zhao G, Gu H, Liao H, Zhu Y, et al. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K\/AKT and MAPK signaling pathways. Cancer Lett. 2012;319:89\u201397.","journal-title":"Cancer Lett"},{"key":"1130_CR46","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.autrev.2018.03.017","volume":"17","author":"T Zhang","year":"2018","unstructured":"Zhang T, De Carolis C, Man GCW, Wang CC. The link between immunity, autoimmunity and endometriosis: a literature update. Autoimmun Rev. 2018;17:945\u201355.","journal-title":"Autoimmun Rev"},{"key":"1130_CR47","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","volume":"48","author":"H Zhang","year":"2020","unstructured":"Zhang H, Shi X, Huang T, Zhao X, Chen W, Gu N, Zhang R. Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res. 2020;48:6251\u201364.","journal-title":"Nucleic Acids Res"},{"key":"1130_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W. m6A-binding proteins: the emerging crucial performers in epigenetics. J Hematol OncolJ Hematol Oncol. 2020;13:35.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"1130_CR49","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMra1810764","volume":"382","author":"KT Zondervan","year":"2020","unstructured":"Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244\u201356.","journal-title":"N Engl J Med"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01130-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:02:51Z","timestamp":1745953371000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01130-8","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the first affiliation was incorrect and has been updated","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was granted by the ethics committee of the First Affiliated Hospital of Xiamen University. Informed consent was obtained from all individual participants included in the study. Ethics approval number: XMYY-2022KYSB012","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that all the authors have read and approved the final manuscript for submission. Additionally, all authors consent to the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}